Category Archives: Announcements

Important bulletins about the library, access and service changes, and library resources

Our ILLiad Webpages Have a New Look!

Posted on by

MSK Library users know and love our ILLiad Document Delivery service. It allows anyone with an MSK email address to access a world of information beyond MSK Library’s highly specialized cancer-related collections. This is a service that is used by researchers throughout MSK to get articles on topics ranging from angioplasty to zebrafish.

Today we’re launching new ILLiad webpages. These pages serve the same functions as before with an updated look. There are a few changes you should know about.

The new pages are mobile friendly, accessible, responsive, and generally updated in their look and feel. We hope the new pages will be intuitive to navigate for users, but if you’re having trouble, please reach out to the Document Delivery Services team.

Now, let’s get down to some specifics. Your login for ILLiad has not changed. It is your MSK network username and your employee ID number – not your MSK password. Once you log in, you may be prompted to update or confirm some information for your user profile. This information will not be shared outside the library and is only used by our staff to contact you about your requests and for some statistics within the library as to who is using our service. Complete the form and click “This information is correct” at the bottom of the page to submit your answers. You will not be able to move on to the request pages without submitting this information.

Once you confirm your contact information, you’ll reach your ILLiad dashboard. The menu items are now along the top and the left-side menu is gone. This includes a new Search field. You can search by request number, author name, article title, and more.

Some of the language has been updated to remove library jargon. The image below shows requests with new, plain language statuses.

ILLiad is still the portal for MSK library users to request scholarly material, retrieve PDF files of articles and book chapters when those requests are complete, and check on interlibrary book loans coming in from libraries across the country. We hope that these new web pages will make your experience using ILLiad even better. If you have any questions, please do not hesitate to reach out to the Document Delivery Services team at ill@mskcc.org.

 

Advancing Authorship Webinar: Preprints in the Time of COVID-19

Posted on by

Join us for the next event in our Advancing Authorship MSK Library Series: Preprints in the Time of COVID-19. 

During the COVID-19 pandemic, research has accelerated at an unprecedented pace and it has become more critical than ever for scientists to rapidly share their research results. Increasingly, researchers are relying on preprints to quickly communicate and share findings. In this session, we will explore the benefits and challenges of preprints. You’ll hear from MSK researchers who have published preprints on COVID-19, plus the Co-founder of two popular preprint servers, bioRxiv and medRxiv. 

Date: Friday, September 25
Time: 12:30 PM – 2:00 PM
Location: Zoom Webinar – REGISTER NOW

Speakers:

John Inglis, PhD – Dr Inglis is the Co-founder of bioRxiv and medRxiv, Cold Spring Harbor Laboratory’s preprint services for the life and health sciences.  He is also the founding Executive Director and Publisher of Cold Spring Harbor Laboratory Press in New York, a not-for-profit publisher of journals, books, and online media in molecular and cellular biology. He graduated from the University of Edinburgh Medical School with a PhD in immunology and was previously Assistant Editor of The Lancet, founding editor of Trends in Immunology, and managing editor of other Trends journals.  Follow John on Twitter @JohnRInglis.

Elizabeth Robilotti, MD, MPH, Dept. of Medicine, Associate Chief Medical Epidemiologist/Assistant Attending Infectious Diseases. Dr. Robilotti’s clinical practice directly influences her research in infection prevention and hospital epidemiology. She is focused on advancing the prevention of healthcare-associated infections  in high risk cancer patients through the application of molecular epidemiology. Through collaborations with the Microbiology Laboratory, Dr. Robilotti also works to refine new techniques  for more accurate and thorough surveillance and outbreak investigation. 

Lior Braunstein, MD, Dept. of Radiation Oncology, MSK – Board-certified radiation oncologist and scientist who specializes in treating breast cancer, prostate cancer, and primary and metastatic brain tumors. Dr. Braunstein has expertise in using advanced radiation therapy techniques, such as intensity-modulated radiation therapy, image-guided radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery. His research is focused on molecular and biomarker-driven clinical trials, cancer epidemiology and outcomes analyses, and translational studies. As part of his clinical and scientific work, Dr. Braunstein serves on several national and international committees including the American Society of Clinical Oncology, the American Society for Radiation Oncology, and NRG Oncology, among others.

Malin Hultcrantz, MD, PhD, Dept. of Medicine, MSK – Hematologist with Clinical Expertise in Multiple Myeloma; Smoldering Myeloma; Monoclonal Gammopathy of Undetermined Significance (MGUS); Related Plasma Cell Disorders